Jia Jie Biomedical (4109) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 加捷生醫

Jia Jie Biomedical (4109) reported revenue of NT$42.1 million for Oct 2026, +8.0% year on year and -15.7% from the previous month. Revenue for Jan–Oct 2026 was NT$452.8 million (+16.0% year on year).

Year-on-year revenue growth: 7 months in a row. →

In Oct 2026, it ranked No. 105 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$34.3 million24/10Nov 2024 NT$33.4 millionDec 2024 NT$61.2 millionJan 2025 NT$31.6 millionFeb 2025 NT$30.9 million25/02Mar 2025 NT$70.2 millionApr 2025 NT$37.2 millionMay 2025 NT$35 millionJun 2025 NT$35.1 million25/06Jul 2025 NT$36.5 millionAug 2025 NT$38.7 millionSep 2025 NT$36.1 millionOct 2025 NT$39 million25/10Nov 2025 NT$36.3 millionDec 2025 NT$57.3 millionJan 2026 NT$37.7 millionFeb 2026 NT$34.4 million26/02Mar 2026 NT$63.2 millionApr 2026 NT$43.8 millionMay 2026 NT$39.6 millionJun 2026 NT$49.3 million26/06Jul 2026 NT$48.7 millionAug 2026 NT$44.1 millionSep 2026 NT$49.9 millionOct 2026 NT$42.1 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$42.1 million+8.0%-15.7%
Sep 2026NT$49.9 million+38.1%+13.2%
Aug 2026NT$44.1 million+13.9%-9.6%
Jul 2026NT$48.7 million+33.3%-1.2%
Jun 2026NT$49.3 million+40.4%+24.4%
May 2026NT$39.6 million+13.2%-9.5%
Apr 2026NT$43.8 million+17.7%-30.7%
Mar 2026NT$63.2 million-10.0%+83.7%
Feb 2026NT$34.4 million+11.2%-8.6%
Jan 2026NT$37.7 million+19.3%-34.3%
Dec 2025NT$57.3 million-6.3%+57.9%
Nov 2025NT$36.3 million+8.6%-6.9%
Oct 2025NT$39 million+13.5%+7.8%
Sep 2025NT$36.1 million+19.5%-6.6%
Aug 2025NT$38.7 million+15.1%+5.8%
Jul 2025NT$36.5 million+19.6%+4.0%
Jun 2025NT$35.1 million-51.1%+0.4%
May 2025NT$35 million-21.3%-6.0%
Apr 2025NT$37.2 million+2.8%-47.0%
Mar 2025NT$70.2 million+19.3%+127.0%
Feb 2025NT$30.9 million-46.3%-2.0%
Jan 2025NT$31.6 million-27.1%-48.4%
Dec 2024NT$61.2 million+147.1%+83.0%
Nov 2024NT$33.4 million-2.2%-2.6%
Oct 2024NT$34.3 million+33.8%+13.5%

Jan–Oct 2026 cumulative: NT$452.8 million (+16.0% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Jia Jie Biomedical vs PEC / Jia Jie Biomedical vs Lotus Pharm / Jia Jie Biomedical vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16